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Abstract
Objectives: This study was aimed to assess the diversity of the meconium microbiome and determine if the bacterial
community is affected by maternal diabetes status.
Methods: The first intestinal discharge (meconium) was collected from 23 newborns stratified by maternal diabetes status: 4
mothers had pre-gestational type 2 diabetes mellitus (DM) including one mother with dizygotic twins, 5 developed
gestational diabetes mellitus (GDM) and 13 had no diabetes. The meconium microbiome was profiled using multi-barcode
16S rRNA sequencing followed by taxonomic assignment and diversity analysis.
Results: All meconium samples were not sterile and contained diversified microbiota. Compared with adult feces, the
meconium showed a lower species diversity, higher sample-to-sample variation, and enrichment of Proteobacteria and
reduction of Bacteroidetes. Among the meconium samples, the taxonomy analyses suggested that the overall bacterial
content significantly differed by maternal diabetes status, with the microbiome of the DM group showing higher alpha-
diversity than that of no-diabetes or GDM groups. No global difference was found between babies delivered vaginally
versus via Cesarean-section. Regression analysis showed that the most robust predictor for the meconium microbiota
composition was the maternal diabetes status that preceded pregnancy. Specifically, Bacteroidetes (phyla) and
Parabacteriodes (genus) were enriched in the meconium in the DM group compared to the no-diabetes group.
Conclusions: Our study provides evidence that meconium contains diversified microbiota and is not affected by the mode
of delivery. It also suggests that the meconium microbiome of infants born to mothers with DM is enriched for the same
bacterial taxa as those reported in the fecal microbiome of adult DM patients.
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Introduction
Prenatal diabetes, which includes both pre-gestational Type 1
and Type 2 diabetes, and gestational diabetes that develops during
pregnancy have been associated with an increased risk of obstetric
and neonatal complications [1–3]. Both pre-gestational and
gestational diabetes have also been associated with major birth
defects [4] and congenital anomalies of the offspring [5,6].
Moreover, gestational diabetes has been linked to the risk of
childhood obesity [7,8], which has both immediate and long-term
implications on human health.
Human microbiome studies have demonstrated dynamic
changes in bacterial composition in the gut during pregnancy
and childhood development [9–11]. Moreover, the presence of
pathogenic species, or absence of beneficial species, in early
childhood has been suggested to play a key role in the initiation of
preterm birth [12], development of asthma or eczema [13,14],
allergy [15], autism [16] or other immunological deficiency
[17,18].
Historically, the fetus, as well as the intrauterine environment,
has been considered sterile, with the initial microbial exposure
taking place at birth vaginally or via C-section through contacting
maternal vaginal or skin microbiota, respectively [9,11,19,20].
However, accumulating evidence suggests the presence of different
microbes in amniotic fluid [21,22], umbilical cord blood [23],
meconium [24,25], and placental [26] and fetal membranes [27].
Studies in mice have demonstrated the transmission of labeled
bacterial strains from a mother to fetus during pregnancy [25].
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Taken together, these results suggest that mother-to-baby efflux of
commensal microbes may occur prior to birth.
However, despite the growing recognition that commensal
microbes may contribute fundamentally to infant and childhood
development and immunity [14,15,17,18,28,29], only a few
studies have determined the microbial composition of the first
intestinal discharge, or meconium, in premature [30–32] and in
term neonates [24,25] and linked its bacterial content to maternal
eczema and infant mucus congestion during the first year of life
[24]. Therefore, the main objectives of this study were to further
characterize the composition of the meconium and assess whether
maternal diabetes status, prior to or during pregnancy, affects
bacterial composition of the newborn’s first stool.
Methods
Subjects
This study was approved by the Mount Sinai Institutional
Review Board. Pregnant women before their second trimester
were recruited during their regular prenatal visits at a prenatal
obstetrics and gynecological (OB/GYN) clinic at Mount Sinai
Medical Center and provided a written informed consent for
themselves and their prospective infants. The exclusion criteria
included: 1) any antibiotic treatment during pregnancy; women
who eventually underwent C-section and received an immediate
dose of Kefzol (cefazolin) ,30 mins prior to C-section as a
standard of care were retained in the study, or 2) obstetric risks,
such as HIV positivity, significant congenital anomalies,
neurological dysfunction, fetal chromosomal anomalies, or
inborn errors in metabolism. Clinical characteristics of the
infant included sex, birth weight (BW), birth length, time of
sampling (hours after birth), neonatal complications, gestational
age, and delivery method. Clinical variables of the mother
included age, body mass index (BMI) at 1st and 3rd trimester,
glucose level (1 hour glucose challenge test, or GCT, completed
at 24–28 weeks), medications during pregnancy, maternal
smoking, and diabetes status. A subclinical group included 4
no-diabetes mothers with glucose levels higher than the cut-off
point of 130 ng/dL, who did not meet the criteria for
gestational diabetes at the diagnostic 3-hour glucose tolerance
test (GTT). Such women are known to carry additional obstetric
risk, such as fetal macrosomia and other morbidities [33,34].
Seven adult fecal samples used for the comparison purposes in
the present study were collected for an unrelated study from
healthy individuals with no diabetes and no antibiotic
treatments for at least 6 months, who consented for their
samples to be used for other research.
Sample collection
The neonate meconium from 23 enrolled infants was
passed ranging between 2 hours and 48 hours after birth
(Table 1). The meconium was transferred from a diaper to
sterile 15 ml Falcon tubes using a sterile tongue depressor by
the research staff and stored at 280uC until processing.
During the sample collection and processing, the mother did
not handle the meconium in order to avoid possible
contaminations.
Fecal DNA extraction and 16S ribosomal RNA (rRNA)
amplification
Total meconium DNA was extracted using Qiagen stool kit
(Qiagen, CA). Subsequent amplification of bacterial 16S rRNA
v3–v4 region using barcoded PCR primers (Table S1 in File S1)
was performed as previously described [35]. A 16-mer error-
correcting Golay barcode was added to the reverse primer. A
composite bar-coded sample for sequencing was created by
combining equimolar amounts of amplicons from the 23
individual samples.
16S rRNA sequencing, taxonomy assignment and
diversity computation
The pooled 16S rRNA PCR amplicons were sequenced on
the Pacbio RS system. Two 45-minute movies were collected on
each SMRT cell. Analysis was performed only on circular
consensus (CCS) reads (CCS reads are generated when $3 full
pass subreads are present). Final CCS reads were filtered by the
sequencing quality score and read length before being exported
to FASTA format. To test the sequencing accuracy and
reproducibility, three healthy adult stool samples were processed
twice and sequenced on two separated SMRT cells. The E.coli
strain BL21 was sequenced to test the classification accuracy.
Filtered high quality CCS reads were further processed by
QIIME 1.5.0 [36]. The alpha-diversity was calculated using the
Shannon Index as metric and represented the mean species
diversity within each sample. The beta diversity was estimated
using both weighted and unweighted UniFrac distance matrices
and represented the measurement of compositional dissimilarity
among samples.
Data Analysis
Wilcoxon-Mann-Whitney test was performed at various OTU
(operational taxa unit) levels to compare between the adult feces
and meconium with regard to and regardless of maternal diabetes
status. P-values were adjusted for false-discovery rate (FDR) using
the Benjamini and Hochberg method [37]. Non-parametric
multiple dimensional scaling (nMDS) and Principal Coordinate
Analysis (PCoA) were used to visualize the dissimilarities of the
overall microbiome. The PerMANOVA test [38,39], with the
maximum number of permutations = 999, was performed using
the [Adonis] function of the R package vegan 2.0–5 [40] to compare
the overall microbiome differences between the meconium
microbiota by maternal diabetes status or type of delivery. We
also performed the univariate regression analysis using the [lm]
function in R.
The dependent variables included the unweighted principle
components (PC): PC1, PC2 and PC3, representing the dominant
taxa Bacteroidetes, Firmicutes and Proteobacteria at the phyla level and
the unweighted UniFrac distance matrices representing the overall
microbiome profile. The predictor included newborn sex, time of
sampling, gestational age, delivery method, maternal BMI at 1st
trimester and maternal diabetes status.
Results
Clinical information
Twenty-three newborns were enrolled in this study (Table 1).
Five of the babies were born to mothers with established DM, 5 to
mothers with GDM, and 13 to mothers with subclinical diabetes
(n = 4) or no diabetes (n = 9). One of the mothers with DM had
dizygotic twins. None of the study participants reported being
smokers. Ten babies were delivered by C-section with the type of
C-sections (emergency or elective), as well as additional participant
characteristics, listed in Table 1. No significant difference was
observed for TOS, BW and length among DM, GDM, and no-
diabetes groups (p-value .0.1 by t-test). Missing data resulted
from the fact that some mothers only consented to certain
components of the study.
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Validation of the sequencing accuracy and
reproducibility
In this study, on average, a single chip generated ,55,000 post-
filtered reads (mean mapped CCS read accuracy about 94%), of
which ,33,000 reads were longer than 2 kilobases (Figure S1A
in File S1). Figure S1B in File S1 demonstrates that the mean
CCS read length was 443 base pairs (bp, ranging between 400 and
500 bp). We tested reproducibility of our 16S rRNA sequencing
technique by comparing duplicate samples. Taxonomy assignment
showed that, the correlation between the duplicates was within the
range of 99.5% to 99.9% at any taxonomy level (Figure S1C in
File S1). When we examined the bacterial composition of the
control E.coli strain BL21, 99.5% of the CCS reads were correctly
assigned at the phyla through family level and 97.1% at the genus
level, suggesting a high accuracy and low misclassification rate
(Figure S1D in File S1).
Bacterial Composition of the Meconium and Comparison
to the Adult and Infant Microbiome
After filtering by quality and length, we obtained, on average,
3,300 CCS reads per sample (range 1,464–6,641). Our results
indicated that all 23 meconium samples were not sterile. At the
phylum level, all four major phyla, Actinobacteria, Bacteroidetes,
Firmicutes and Proteobacteria, were represented accounting for about
99% of the microbial content (Figure 1A). However, the average
taxa abundance of the newborn meconium was very different from
that of the adult stool samples (Figure 1B). Specifically, when
compared with the adult feces (Figure 2), the meconium from the
neonates born to no-diabetes (healthy and preclinical DM)
mothers had a significantly higher proportion of Proteobacteria
(71.0% in the meconium vs. 3.1% in the adult stool), and a lower
proportion of Bacteroidetes (2.5% in the meconium vs. 42.8% in the
adult stool), Firmicutes (20.0% in the meconium vs. 44.7% in the
adult stool) and Verrucomicrobia (0.06% in the meconium vs. 3.2% in
the adult stool) (FDR-adjusted p,0.05). At the family level,
Comamonadaceae and Enterobacteriaceae were significantly enriched in
the meconium samples compared to the adult stool (FDR-adjusted
p,0.05). Further analyses showed a significant reduction in
Bacteroidaceae, Lachnospiraceae, Ruminococcaceae and Veillonellaceae
(FDR-adjusted p,0.05) in the meconium. The four most
abundant genera in the meconium included Comamonas, Escherich-
ia/Shigella, Klebsiella and Proteus. Similar to the no-diabetes group,
the meconium from DM and GDM groups also showed
enrichment of Proteobacteria and reduction of Bacteroidetes and
Firmicutes, in comparison with the adult stool samples.
As the composition of the first stool is likely to change in
response to environmental exposures, we compared the meconium
microbiome content to the reported microbiome profiles from
early infancy [9,19,20,41]. Our data showed that, although at the
phylum level, the meconium is more similar to that of infants than
to adults, at the genus level, the dominant taxa found in the early
infant stool from vaginal deliveries (Lactobacillus, Prevotella) or from
C-sections (Acinetobacter, Propionibacterineae, Micrococcineae, Corynebac-
terineae) [9,11,19,41] were not prevalent (,1%) in over 90% of the
meconium samples.
Diversity of the Meconium Microbiota
The average microbiota diversity within the meconium
microbiome was lower than that of adult feces (3.1 vs. 8.5,
p = 1.7e-4, Figure 1C). Within meconium samples, the DM group
showed higher alpha-diversity (within-sample bacterial diversity)
than that from the no-diabetes or GDM groups (6.2 vs. 3.1 and
2.9; FDR-adjusted p = 1e-3 and 0.08, respectively). Meconium
samples of babies born to mothers with no diabetes or GDM had a
higher variability in beta-diversity (between-sample bacterial
diversity) than the DM group (p = 0.006 and 0.0017 by F-test,
respectively) or the adult samples (p = 3e-5 and 2.3e-4 by F- test,
respectively) (Figure S2A in File S1). The DM group showed a
lower variability than the adult samples.
Meconium Microbiome and Maternal Diabetes Status
The nMDS analysis using unweighted UniFrac distance
matrices showed a considerable separation of the overall
microbiota by maternal diabetes status (Figure 3). The PerMA-
NOVA test detected that the DM and GDM groups were each
significantly different from the no-diabetes group (p = 0.004, 0.022,
respectively); however no significant difference was observed
between the DM and GDM groups (p = 0.16). Consistent with
the PerMANOVA results, weighted and unweighted UniFrac
PCoA showed a separation of the DM from no-diabetes samples
on the PC1 vs. PC2 plot (Figure S2B in File S1), mostly driven
by the enrichment of Bacteroidetes and reduction of Proteobacteria in
the DM meconium samples (Figure S3 in File S1). Notably, the
4 subjects with subclinical DM (subjects BM3, BM180, BM52 and
BM276) showed no separation from other no-diabetes samples
(Figure S3 in File S1). Furthermore, we compared the
abundance of the OTUs among these three groups. Figure 4
depicts all OTUs that showed significant difference (p,0.05) at the
phylum, class, family and genus level between DM and no-
diabetes controls. Specifically, several OTUs, such as Bacteroidetes
(phyla), Lachnospiraceae (family) and Parabacteriodes (genus) that were
enriched in adult Type 2 diabetes patients [42], were also
significantly enriched in the meconium samples of babies born to
DM mothers compared to the no-diabetes group. No significance
was achieved when p-values were adjusted for multiple hypothesis
testing.
Relationship between the Meconium Microbiome and
Other Maternal and Newborn Characteristics
Previous work has shown the association of the infant
microbiome with the delivery mode [9,20]. In our study, the
PerMANOVA test showed no significant difference between the
two delivery methods in neonates born to no-diabetes mothers
(p = 0.26). The weighted and unweighted PCoA plot also showed
no separation (Figure S2C in File S1). Moreover, we found no
significant differences in taxa between the two delivery modes at
each OTU level. Despite the small sample size, we further
investigated the impact of the type of C-section (i.e., emergency or
elective) on newborn’s gut microbiota and found no significant
differences between the microbiome profiles of the 8 emergency
and 2 elective C-sections.
In the univariate regression analysis, we found that the maternal
diabetes status was significantly associated with the abundance of
Bacteroidetes (p = 0.029), PC2 (p = 0.015) and the overall microbiome
profile (p = 0.038) (Table S2 in File S1). No other demographic
or clinical characteristics were found to be associated with the
meconium microbiome profile.
Discussion
We implemented 16S rRNA sequencing using the Pacbio RS
system to explore the meconium microbiome of 23 newborns. Our
findings showed that the meconium was not sterile in all of our
study subjects and contained diverse microbiota communities,
regardless of the demographic and clinical characteristics. A
number of studies using culture-dependent or independent
methods have established the presence of live bacteria in the fetus
Meconium Microbiota and Maternal Diabetes Status
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prior to birth [12,21–26,30–32,43]. However, until the develop-
ment of the next generation sequencing (NGS) technology, the
detailed characterization of the microbiome at the taxa level was
challenging. Moreover, while a number of studies have compared
the bacterial composition of the adult stool with early infant stool
[9,11,19,20,28], only a handful of small studies have been carried
out in meconium [24,25,32]. Using a culture-independent NGS
technology, we demonstrated that the meconium microbiota
substantially differ from those in adult feces, with the overall
microbiome diversity being significantly lower than that of the
adult stool (Figure 1). While at the phylum level the meconium
microbiome was more similar to that of infants [9,11,19,41] than
adults, at the genus level, the dominant taxa found in the early
infant stool were not prevalent in the meconium samples.
Figure 1. Comparison of the microbiota communities of neonate meconium to adult stool samples. A. Classification of the microbiota at
the Phylum level. Samples BM62-BM140 are neonate meconium and 7 samples are from healthy adults. The total reads for each sample are
normalized to 2000. Neonate meconium samples are grouped by maternal clinical status: Healthy, subclinical, GDM (gestational diabetes) and DM
(type 2 diabetes). B. Average taxa abundances between the neonate meconium and adult stool samples. HC group combined healthy and subclinical
samples. C. Alpha rare plot shows the average microbiota diversity of the neonate meconium grouped by maternal status (HC, GDM and DM) and
adult stool samples.
doi:10.1371/journal.pone.0078257.g001
Meconium Microbiota and Maternal Diabetes Status
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Figure 2. Comparison of the OTUs at the Phylum and Family level between healthy adult stool samples and the meconium samples
from neonates born to mothers with no diabetes. The meconium samples included both HC and subclinical groups. Only OTUs shown
significance (p values ,0.05 by WMW-test and adjusted by BH method) between the two groups are presented.
doi:10.1371/journal.pone.0078257.g002
Figure 3. Comparison of meconium microbiota from neonates born to HC (healthy), DM (type 2 diabetes) and GDM (gestational
diabetes) mothers using nMDS ordination. The unweighted UniFrac distance matrices generated from QIIME were visualized in nMDS plot.
Lines connect individual communities to the centroid values for each group. The ellipses were drawn to represent the class standard errors.
doi:10.1371/journal.pone.0078257.g003
Meconium Microbiota and Maternal Diabetes Status
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Among the meconium samples, we observed a significant
increase in the diversity of various bacterial types if mothers had
pre-gestational DM compared to those with no diabetes or GDM.
These results are also consistent with the recent findings that
have suggested that certain microbiota components are more
prevalent in adult individuals with DM [42,44]. Specifically, at the
Figure 4. List of OTUs that showed significant difference between neonates from mothers with different diabetes states. HC(healthy)
group was combined with both healthy and subclinical groups. *unadjusted p-value from WMW-test between HC and DM(type 2 diabetes) group;
**unadjusted p-value from WMW-test between HC and GDM(gestational diabetes) group.
doi:10.1371/journal.pone.0078257.g004
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OTU level, the Bacteroides, Parabacteroides and Lachnospiraceae, which
have been reportedly prevalent in adult diabetes patients [29,42],
were enriched in the meconium of babies born to mothers with
DM. Despite the enrichment of certain bacteria, a previous study
have reported no difference in the mean OTU diversity within
each sample between the adult DM cases and controls [45].
However, in our study, we observed that the meconium in the DM
group showed higher alpha-diversity than that in the no-diabetes
or GDM groups with a possible explanation being that the
bacterial transmission to fetus may be more permissible under
maternal diabetic conditions.
An additional illustration of the link between the meconium
microbiota composition and maternal and infant health has been
provided by Gosalbes et al., who reported that the meconium
microbiota types dominated by lactic acid or enteric bacteria are
differentially associated with maternal eczema and respiratory
problems in infants [24]. Moreover, they have shown that some of
the species that reach the fetal gastrointestinal tract prenatally can
be present in the infant long into the first year, underlining the
potential long-term clinical consequences of the initial microbiota
content. We speculate that the bacterial diversity in the gut of a
fetus may reflect pathophysiological processes occurring during
pregnancy or represent a direct transmission of maternal intestinal
bacteria. Prospective studies will be required to further clarify the
path of the mother-to-baby efflux of commensal microbes during
pregnancy, as well as the impact of the maternal microbiome on
predisposition to adult-onset diseases.
Microbiome studies of early infancy have demonstrated a
significant effect of the mode of delivery on the microbiome
composition, suggesting the likely association of the infant gut
bacteria with maternal vaginal or skin microbiome habitats [9,20].
However, in our study, no significant differences in the overall
microbiome composition by the mode of delivery were detected in
babies born to mothers with and without diabetes. Furthermore,
we observed that neither of the dominant OTUs reported
previously [9] at the genus level in the stool of young infants
delivered vaginally (Lactobacillus, Prevotella) or via C-section
(Acinetobacter, Propionibacterineae, Micrococcineae, Corynebacterineae) were
prevalent in the majority of the meconium samples. Instead, the
most common OTUs at the genus level in the meconium included
Comamonas, Escherichia/Shigella, Klebsiella and Proteus, which are
predominantly aerobic or facultative anaerobic organisms. Coma-
monas was found in human appendix, a small pouch attached to
the first portion of the large intestine [46] and Escherichia/Shigella,
Klebsiella and Proteus occur naturally in the human gut [47], further
supporting our hypothesis that the initial colonization in the
human gut starts prior to birth. While our findings are consistent
with a recent report that also showed no substantial overlap of the
meconium microbiota with maternal habitats, especially in babies
born via C-section [24], it contrasts previous analyses demon-
strating that the microbiota recovered from multiple newborn sites
closely resembles vaginal or skin microbiota, depending on the
mode of delivery [9]. Emerging studies point toward pregnancy as
the beginning of bacterial exposure for the developing fetus [23–
25]. A recent study on the microbiome dynamics in the gut of
pregnant women has shown that the bacterial composition evolves
between the 1st and 3rd trimesters, with the maternal gut
microbiome in the 3rd trimester being more similar to what we
observed in the meconium, including the increased variability in
beta-diversity, the compositional dissimilarity among samples,
increasing abundance of Proteobacteria, and the reduction in alpha-
diversity between samples [48]. Taken together, it further suggests
that the maternal microbiota can be transferred to the fetus during
pregnancy.
For this study, we used the Pacbio RS system. Compared with
other NGS platforms, Pacbio RS has the advantage of a much
shorter sequencing time (1 to 2 hours) and the much longer read
length (up to 8,000 bases). However, the embedded relatively high
random sequencing error rate was until recently considered a
limiting factor for applying this technology to 16S-based taxonomy
assignment and phylogenetic analysis. Our result showed that
using CCS reads we were able to replicate an earlier experiment
and correctly assign the OTUs to at least the genus level.
This study’s limitations include the fact that the sample size may
not have allowed us to detect modest differences in bacterial
distribution. Nevertheless, it was comparable to the size of a recent
study with similar objectives and design [24] and allowed us to
detect significant differences with regard to maternal diabetes
status. Also, we did not have access to the matched maternal
samples; thus, evidence connecting the fetal microbiome directly
to the maternal microbiome is lacking. Future studies comparing
bacterial composition of the matched maternal (vaginal, placental
and fecal) and neonatal microbiome are warranted to determine
the major source of the newborn microbiota. In addition, since the
gut microbiota changes dramatically during pregnancy [48], a
direct comparison between pregnant and non-pregnant women
with DM will be important to explore the effect of pregnancy on
bacterial content in the context of DM. Furthermore, numerous
prenatal factors, such as chorioamnonitis or premature rupture of
membranes, maternal prenatal smoking, maternal stress, and
others , may contribute to the initial colonization of the gut
microbiome. Women were also excluded from the study if they
received antibiotic treatment over the course of pregnancy,
precluding testing the relationship between maternal infection,
diabetes, and meconium content. However, women undergoing
C-section and receiving a prophylactic dose of an antibiotic as a
standard of care were retained in the study, which could
potentially affect the meconium microbiota, especially if antibiotics
were given before cord clamping. The sample size of this study
would not allow to systematically assess the effect of these and
other factors on the meconium microbiome profile. Larger studies
collecting extensive prenatal and neonatal data are underway to
explore the role of other factors that have effects on the meconium
microbiome. Also, health-related information, such as BMI,
maternal smoking or glucose level, was not accessible on several
enrolled subjects due to the lack of consent or ethical issues
associated with administering GCT to individuals with established
DM. Therefore, we were unable to establish the relationship
between these traits and the meconium microbial composition.
Moreover, the time of sampling widely varied among the
newborns raising the possibility that environmental exposures
may have influenced the bacterial content for those who passed
their first stool at a later time. However, the time of sampling was
not significantly different between the study groups; therefore, it is
unlikely to systematically bias our results. Also, it is known that
maternal diabetes can increase the risk of pre-term birth, due to an
increase in both fetal and maternal indications for delivery. In our
study, we did not see microbiota differences by gestational age
among DM, GDM, and no-diabetes groups; however, future
studies with a larger sample size will have to examine whether
gestational age at delivery is associated with the meconium
microbiota. In addition, we did not account for susceptibility loci
predisposing to DM, which could also be transmitted from a
mother to an infant and potentially affect the microbiome. Future
studies will have to determine if host DM risk alleles are associated
with a ‘‘diabetic’’ microbial profile.
In summary, our study provides further evidence that meconi-
um contains diversified microbiota and suggests that the initial
Meconium Microbiota and Maternal Diabetes Status
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colonization of the gut flora may start prior to birth. Furthermore,
the meconium microbiome of babies born to DM mothers is
enriched for the bacterial OTUs observed in the fecal microbiome
of adult DM patients. These findings can enhance our under-
standing of a non-genetic risk of transmission of DM, and help
design novel preventive measures for adult onset diseases.
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